Viewing Study NCT02730195


Ignite Creation Date: 2025-12-24 @ 1:13 PM
Ignite Modification Date: 2026-02-24 @ 3:13 PM
Study NCT ID: NCT02730195
Status: TERMINATED
Last Update Posted: 2019-01-09
First Post: 2016-03-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia
Sponsor: Emory University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myelogenous Leukemia, BCR-ABL1 Positive View
None Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive View
Keywords: